Oral (standard strength) combined hormonal contraceptives (Formulary: Sexual Health)

TAM (Treatments and Medicines) NHS Highland
NHS Highland

FSRH CEU Guidance: Drug Interactions with Hormonal Contraception (May 2022).
SPS article: Using contraception with enzyme-inducing medicines (June 2023).

ETHINYLESTRADIOL WITH LEVONORGESTREL

Therapy notes

Formulation and dosage details

Formulation:

Tablets (Rigevidon®) (levonorgestrel 150 micrograms, ethinylestradiol 30 micrograms) (equivalent to Microgynon 30®)

FIRST LINE USE

Formulation and dosage details

Formulation:

Tablets, with 7 inactive tablets (Microgynon 30 ED®) (levonorgestrel 150 micrograms, ethinylestradiol 30 micrograms) 

Formulation and dosage details

Formulation:

Tablets (Triregol®) (ethinylestradiol 30 micrograms, levonorgestrel 50 micrograms; ethinylestradiol 40 micrograms, levonorgestrel 75 micrograms; ethinylestradiol 30 micrograms, levonorgestrel 125 micrograms) (equivalent to Logynon®)

ETHINYLESTRADIOL WITH NORGESTIMATE

Therapy notes

Formulation and dosage details

Formulation:

Tablets (Cilique®) (norgestimate 250 micrograms, ethinylestradiol 35 micrograms)

ETHINYLESTRADIOL WITH DESOGESTREL

Therapy notes

Formulation and dosage details

Formulation:

Tablets (Gedarel®) (desogestrel 150 micrograms, ethinylestradiol 30 micrograms) (equivalent to Marvelon®)

ETHINYLESTRADIOL WITH GESTODENE

Therapy notes

Formulation and dosage details

Formulation:

Tablets (Millinette®) (gestodene 75 micrograms, ethinylestradiol 30 micrograms) (equivalent to Femodene®)

Editorial Information

Document Id: F372